| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | ML239 |
|---|
| Description | ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC50 of 1.16 μM with 24-fold selectivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cytokine pathways. MW: 346.6. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N'-[(Z)-pyrrol-2-ylidenemethyl]-2-(2,4,6-trichlorophenoxy)acetohydrazide; (2,4,6-Trichlorophenoxy)-acetic acid (1H-pyrrol-2-ylmethylene)-hydrazide; CID-49843203 |
|---|
| Gene, Accession, CAS # | CAS: 1378872-36-6 |
|---|
| Catalog # | 2696-25 |
|---|
| Price | |
|---|
| Order / More Info | ML239 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|